GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
63.48
+1.79 (2.90%)
At close: Jul 17, 2026, 4:00 PM EDT
62.85
-0.63 (-0.99%)
After-hours: Jul 17, 2026, 7:40 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $1.88 billion as of July 17, 2026. Its market cap has decreased by -17.92% in one year.
Market Cap
1.88B
Enterprise Value
1.88B
1-Year Change
-17.92%
Ranking
Category
Stock Price
$63.48
ChartMarket Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $1.88B, a decrease of -89.47%. That is a compound annual growth rate of -32.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 1.88B | -49.87% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 5.68B |
| Sotera Health Company | 5.21B |
| RadNet | 4.95B |
| Veracyte | 4.73B |
| Adaptive Biotechnologies | 3.54B |
| GRAIL | 3.09B |
| CareDx | 2.08B |
| NeoGenomics | 1.93B |